Dubiotech Bets On ''If You Build It, They Will Come,'' Despite Funding Shortages
This article was originally published in PharmAsia News
Executive Summary
Dubai-based biotech research park Dubiotech unveiled plans for what it is calling a "state-of-art nucleotide laboratory complex," hoping it will draw multinational tenants to the Middle East in force
You may also be interested in...
Quintiles Continues Eastward Push, Looks To Russia And Middle East For Growth
The U.S. CRO sees opportunities to align with young, domestic biopharma companies in emerging markets.
Pfizer, Merck Drop Prices For 67 Drugs In UAE; More Reductions Expected
Pfizer Inc. and Merck Sharp & Dohme will reduce prices of 67 drugs in the United Arab Emirates starting July 1, according to the UAE Ministry of Health
Pfizer, Merck Drop Prices For 67 Drugs In UAE; More Reductions Expected
Pfizer Inc. and Merck Sharp & Dohme will reduce prices of 67 drugs in the United Arab Emirates starting July 1, according to the UAE Ministry of Health